Catheter Precision Inc. (AMEX:VTAK)’s traded shares stood at 0.72 million during the latest session, with the company’s beta value hitting -0.41. At the last check today, the stock’s price was $0.70, to imply a decrease of -20.40% or -$0.18 in intraday trading. The VTAK share’s 52-week high remains $8.40, putting it -1100.0% down since that peak but still an impressive 55.71% since price per share fell to its 52-week low of $0.31. The company has a valuation of $1.95M, with an average of 20.65 million shares in intraday trading volume over the past 10 days and average of 3.38 million shares over the past 3 months.
Catheter Precision Inc. (AMEX:VTAK) trade information
After registering a -20.40% downside in the latest session, Catheter Precision Inc. (VTAK) has traded red over the past five days. The 5-day price performance for the stock is -23.42%, and 63.71% over 30 days. With these gigs, the year-to-date price performance is -82.76%. Short interest in Catheter Precision Inc. (AMEX:VTAK) saw shorts transact 46547.0 shares and set a 0.1 days time to cover.
3 Tiny Stocks Primed to Explode
The world's greatest investor — Warren Buffett — has a simple formula for making big money in the markets. He buys up valuable assets when they are very cheap. For stock market investors that means buying up cheap small cap stocks like these with huge upside potential.
We've set up an alert service to help smart investors take full advantage of the small cap stocks primed for big returns.
Click here for full details and to join for free
Sponsored
Catheter Precision Inc. (VTAK) estimates and forecasts
Looking at statistics comparing Catheter Precision Inc. share performance against respective industry, we note that the company has outperformed competitors. Catheter Precision Inc. (VTAK) shares are -87.27% down over the last 6 months, with its year-to-date growth rate higher than industry average at 92.80% against 13.80%. The rating firms project that company’s revenue will grow 621.70% compared to the previous financial year.
Revenue forecast for the current quarter as set by 1 analysts is 1.06M. Meanwhile, for the current quarter, a total of 1 analyst(s) estimate revenue growth to 1.66M.Earnings reports from the last fiscal year show that sales brought in 133k and 128k respectively in the corresponding quarters. In this case, analysts estimate current quarter sales to rise 697.00% before jumping 1,196.90% in the following quarter.
VTAK Dividends
Catheter Precision Inc. has its next earnings report out on 2024-Dec-19. However, it is important to take into account that this dividend yield ratio is just an indicator to only serve the purpose of guidance. Investors interested to invest in the stock should ponder company’s other fundamental and operations related aspects too.
Catheter Precision Inc. (AMEX:VTAK)’s Major holders
Catheter Precision Inc. insiders hold 16.78% of total outstanding shares, with institutional holders owning 2.53% of the shares at 3.04% float percentage. In total, 2.53% institutions holds shares in the company.
We also have Fidelity Extended Market Index Fund and Fidelity Series Total Market Index Fund as the top two Mutual Funds with the largest holdings of the Catheter Precision Inc. (VTAK) shares. Going by data provided on Aug 31, 2024, Fidelity Extended Market Index Fund holds roughly 4.06 shares. This is just over 0.41% of the total shares, with a market valuation of $2801.0. Data from the same date shows that the other fund manager holds a little less at 48.0, or 0.00% of the shares, all valued at about 33.0.
